JP Morgan Chase’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Sell |
197,815
-8,354
| -4% | -$61K | ﹤0.01% | 4385 |
|
|
2025
Q4 | $1.26M | Buy |
206,169
+2,562
| +1% | +$27.7K | ﹤0.01% | 4440 |
|
|
2025
Q3 | $3.75M | Sell |
203,607
-3,292
| -2% | -$52.9K | ﹤0.01% | 3608 |
|
|
2025
Q2 | $2.69M | Sell |
206,899
-25,613
| -11% | -$303K | ﹤0.01% | 3685 |
|
|
2025
Q1 | $2.46M | Sell |
232,512
-3,856
| -2% | -$61.2K | ﹤0.01% | 3724 |
|
|
2024
Q4 | $4.01M | Sell |
236,368
-20,348
| -8% | -$383K | ﹤0.01% | 3562 |
|
|
2024
Q3 | $5.96M | Sell |
256,716
-15,291
| -6% | -$327K | ﹤0.01% | 3089 |
|
|
2024
Q2 | $6.62M | Sell |
272,007
-45,544
| -14% | -$1.38M | ﹤0.01% | 2816 |
|
|
2024
Q1 | $10.7M | Sell |
317,551
-5,268
| -2% | -$187K | ﹤0.01% | 2416 |
|
|
2023
Q4 | $10.2M | Sell |
322,819
-4,830
| -1% | -$115K | ﹤0.01% | 2460 |
|
|
2023
Q3 | $8.37M | Sell |
327,649
-10,873
| -3% | -$335K | ﹤0.01% | 2403 |
|
|
2023
Q2 | $9.71M | Sell |
338,522
-3,318
| -1% | -$90.3K | ﹤0.01% | 2310 |
|
|
2023
Q1 | $8.19M | Sell |
341,840
-1,337
| -0.4% | -$24K | ﹤0.01% | 2448 |
|
|
2022
Q4 | $5.82M | Sell |
343,177
-2,974
| -0.9% | -$51.9K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $5.13M | Buy |
346,151
+21,091
| +6% | +$354K | ﹤0.01% | 2717 |
|
|
2022
Q2 | $5.12M | Sell |
325,060
-75
| -0% | -$1.47K | ﹤0.01% | 2782 |
|
|
2022
Q1 | $8.77M | Sell |
325,135
-29,442
| -8% | -$751K | ﹤0.01% | 2503 |
|
|
2021
Q4 | $13.1M | Buy |
354,577
+120,744
| +52% | +$4.92M | ﹤0.01% | 2206 |
|
|
2021
Q3 | $11.2M | Sell |
233,833
-31,917
| -12% | -$1.43M | ﹤0.01% | 2286 |
|
|
2021
Q2 | $8.99M | Buy |
265,750
+23,690
| +10% | +$802K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $10M | Buy |
242,060
+123,207
| +104% | +$7.34M | ﹤0.01% | 2356 |
|
|
2020
Q4 | $5.16M | Buy |
118,853
+75,381
| +173% | +$5.11M | ﹤0.01% | 2786 |
|
|
2020
Q3 | $1.86M | Buy |
43,472
+9,320
| +27% | +$463K | ﹤0.01% | 3283 |
|
|
2020
Q2 | $1.6M | Buy |
34,152
+12,996
| +61% | +$448K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $288K | Sell |
21,156
-43,013
| -67% | -$550K | ﹤0.01% | 4110 |
|
|
2019
Q4 | $698K | Buy |
64,169
+17,825
| +38% | +$187K | ﹤0.01% | 4072 |
|
|
2019
Q3 | $476K | Buy |
46,344
+33,099
| +250% | +$358K | ﹤0.01% | 4200 |
|
|
2019
Q2 | $128K | Buy |
+13,245
| New | +$97.2K | ﹤0.01% | 4834 |
|
|
2018
Q4 | – | Sell |
-16,744
| Closed | -$148K | – | 5672 |
|
|
2018
Q3 | $148K | Buy |
16,744
+8,008
| +92% | +$66.7K | ﹤0.01% | 4800 |
|
|
2018
Q2 | $74K | Buy |
+8,736
| New | +$56.6K | ﹤0.01% | 4943 |
|
|
2018
Q1 | – | Sell |
-11,899
| Closed | -$95K | – | 5368 |
|
|
2017
Q4 | $95K | Buy |
+11,899
| New | +$107K | ﹤0.01% | 4682 |
|
|
2017
Q2 | – | Sell |
-757
| Closed | -$6K | – | 4940 |
|
|
2017
Q1 | $6K | Buy |
+757
| New | +$7.01K | ﹤0.01% | 4871 |
|
|
2016
Q2 | – | Sell |
-386
| Closed | -$10K | – | 4755 |
|
|
2016
Q1 | $10K | Buy |
+386
| New | +$13.1K | ﹤0.01% | 4241 |
|
|
2014
Q4 | – | Sell |
-87,335
| Closed | -$9.44M | – | 4210 |
|
|
2014
Q3 | $9.44M | Sell |
87,335
-30,842
| -26% | -$4.02M | ﹤0.01% | 1959 |
|
|
2014
Q2 | $14.3M | Buy |
118,177
+2,739
| +2% | +$331K | ﹤0.01% | 1529 |
|
|
2014
Q1 | $14.7M | Buy |
115,438
+29,882
| +35% | +$4.43M | ﹤0.01% | 1508 |
|
|
2013
Q4 | $10.8M | Buy |
85,556
+42,915
| +101% | +$5.39M | ﹤0.01% | 1730 |
|
|
2013
Q3 | $5.38M | Buy |
42,641
+8,355
| +24% | +$743K | ﹤0.01% | 2137 |
|
|
2013
Q2 | $1.64M | Buy |
+34,286
| New | +$1.68M | ﹤0.01% | 2930 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
